Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alfateq
Edinburgh, Scotland, United Kingdomalfateq.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Alfateq was a specialist drug delivery company based in the United Kingdom, focused on enhancing the bioavailability and solubility of poorly water-soluble therapeutic agents. The company developed a proprietary platform known as Advanced Liquid Formulation Technology (AlfaTeQ), which utilizes lipid-based micro-emulsion systems for oral and transmucosal drug delivery. In 2003, Alfateq was acquired by Vectura Group to integrate its liquid formulation expertise into Vectura's broader respiratory and neurology pipelines. The AlfaTeQ technology has since been utilized to improve the pharmacokinetic profiles and onset of action for various drugs, particularly in the fields of pain management and respiratory health.
- Therapeutic areas
- PulmonologyNeurology
- Modalities
- Small moleculeLipid nanoparticle delivery therapyMicro-emulsion
- Industry
- Biotech
02
Partnerships
Vectura
Beyond the preview
Go deeper on Alfateq.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Alfateq.